China Cord Blood traded at $3.00 this Friday July 1st, increasing $0.04 or 1.35 percent since the previous trading session. Looking back, over the last four weeks, China Cord Blood gained 4.53 percent. Over the last 12 months, its price fell by 44.34 percent. Looking ahead, we forecast China Cord Blood to be priced at 3.18 by the end of this quarter and at 2.76 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
3.00
Daily Change
1.35%
Yearly
-44.34%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Concord Medical Services Hldg 1.95 0.07 3.72% -33.90%
Cerus 5.48 0.19 3.59% -2.32%
China Cord Blood 3.00 0.04 1.35% -44.34%
Plus Therapeutics, Inc. 0.54 0 0% -77.59%
Enzo Biochem 2.14 0.07 3.38% -33.13%
Mednax 21.97 0.96 4.57% -26.86%


China Cord Blood
Global Cord Blood Corporation, formerly China Cord Blood Corporation, is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.